Literature DB >> 12585335

Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.

Nurit Kaiser1, Gil Leibowitz, Rafael Nesher.   

Abstract

Type 2 diabetes mellitus is increasing worldwide with a trend of declining age of onset. It is characterized by insulin resistance and a progressive loss of beta-cell function. The ability to secrete adequate amounts of insulin is determined by the functional integrity of beta-cells and their overall mass. Glucose, the main regulator of insulin secretion and production, exerts negative effects on beta-cell function when present in excessive amounts over a prolonged period. The multiple metabolic aberrations induced by chronic hyperglycemia in the beta-cell include increased sensitivity to glucose, increased basal insulin release, reduced response to stimulus to secrete insulin, and a gradual depletion of insulin stores. Inadequate insulin production during chronic hyperglycemia results from decreased insulin gene transcription due to hyperglycemia-induced changes in the activity of beta-cell specific transcription factors. Hyperglycemia may negatively affect beta-cell mass by inducing apoptosis without a compensatory increase in beta-cell proliferation and neogenesis. The detrimental effect of excessive glucose concentrations is referred to as 'glucotoxicity'. The present review discusses the role of glucotoxicity in beta-cell dysfunction in type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12585335     DOI: 10.1515/jpem.2003.16.1.5

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  60 in total

Review 1.  SGLT2 inhibition--a novel strategy for diabetes treatment.

Authors:  Edward C Chao; Robert R Henry
Journal:  Nat Rev Drug Discov       Date:  2010-05-28       Impact factor: 84.694

2.  Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Authors:  L Zazzeroni; G Lanzoni; G Pasquinelli; C Ricordi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2017-09-29

3.  In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact.

Authors:  Chantel Kowalchuk; Celine Teo; Virginia Wilson; Araba Chintoh; Loretta Lam; Sri Mahavir Agarwal; Adria Giacca; Gary J Remington; Margaret K Hahn
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

4.  Triglyceride-glucose index as predictor for future type 2 diabetes mellitus in a Chinese population in southwest China: a 15-year prospective study.

Authors:  Ziqiong Wang; Liming Zhao; Sen He
Journal:  Endocrine       Date:  2021-01-12       Impact factor: 3.633

5.  Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic β-cell survival and function via CREB.

Authors:  Yanling Zhang; Wei Zhen; Pierre Maechler; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

Review 6.  AMP-activated protein kinase and metabolic control.

Authors:  Benoit Viollet; Fabrizio Andreelli
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase.

Authors:  Shelly Hogan; Lei Zhang; Jianrong Li; Shi Sun; Corene Canning; Kequan Zhou
Journal:  Nutr Metab (Lond)       Date:  2010-08-27       Impact factor: 4.169

8.  The possible role of epigenetics in gestational diabetes: cause, consequence, or both.

Authors:  J L Fernández-Morera; S Rodríguez-Rodero; E Menéndez-Torre; M F Fraga
Journal:  Obstet Gynecol Int       Date:  2010-10-31

9.  Maternal high-fat feeding leads to alterations of brain glucose metabolism in the offspring: positron emission tomography study in a porcine model.

Authors:  Elena Sanguinetti; Tiziana Liistro; Marco Mainardi; Silvia Pardini; Piero A Salvadori; Alessandro Vannucci; Silvia Burchielli; Patricia Iozzo
Journal:  Diabetologia       Date:  2016-01-05       Impact factor: 10.122

10.  Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.

Authors:  Junqin Chen; Ghislaine Fontes; Geetu Saxena; Vincent Poitout; Anath Shalev
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.